Clinical Trial Update: GSNOR Phenotyping/GSNO Challenge in Severe Asthma [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating GSNOR phenotyping and GSNO challenge in severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: James Reynolds | Conditions: Asthma, Healthy Volunteers | EARLY_Phase 1 | Status: COMPLETED